Literature DB >> 9396039

Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts.

A Vigano1, C Balotta, D Trabattoni, D Bricalli, L Crupi, E Palomba, L Galli, A Salvaggio, M L Fusi, S Ruzzante, E Massironi, M C Colombo, N Principi, M Galli, M Clerici.   

Abstract

We analyzed immunologic (CD4 and CD8 slopes; interferon-gamma, interleukin-2, interleukin-10, and chemokines production; concentration of IgE; beta 2-microglobulin) and virologic (p24; HIV isolability and phenotype; plasma viremia) parameters in HIV vertically infected children > or = 8 years of age without disease progression or mild symptoms and an absolute CD4+ count > or = 500/microliter with CD4+ percentage > or = 25%. The results were compared to those of two control groups: (1) slow progressors, children > or = 8 years of age with moderate symptomatology and/or moderate CD4 depletion, and (2) progressors, children > or = 8 years of age with severe clinical disease and/or severe CD4 depletion. Pediatric long-term resistant hosts were characterized by higher production of interleukin-2 and interferon-gamma and lower production of interleukin-10, normal concentration of IgE, HIV isolates with a non-syncytium-inducing phenotype, and lower plasma viremia. This condition was not associated with the concentration of beta 2-microglobulin, p24, and chemokines, or with HIV isolability. The IL-10/IL-2 ratio best correlated with both CD4 counts and disease progression. Thus, vertically infected children showing resistance to disease progression are immunologically and virologically distinct from those in whom progressive HIV infection is observed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396039     DOI: 10.1159/000164119

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  4 in total

1.  Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.

Authors:  X-D Yao; R W Omange; B M Henrick; R T Lester; J Kimani; T B Ball; F A Plummer; K L Rosenthal
Journal:  Mucosal Immunol       Date:  2013-06-26       Impact factor: 7.313

2.  Vertically transmitted HIV infection having first clinical manifestations at 13 y of age.

Authors:  Amitabh Sagar; Biju Vasudevan
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

3.  Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?

Authors:  M Hainaut; V Verscheure; M Ducarme; L Schandené; J Levy; F Mascart
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

4.  Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants.

Authors:  Livia Pedroza-Martins; W John Boscardin; Deborah J Anisman-Posner; Dominique Schols; Yvonne J Bryson; Christel H Uittenbogaart
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.